BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $25,000 | -56.9% | 19,104 | -65.6% | 0.00% | – |
| Q3 2019 | $58,000 | -37.0% | 55,535 | +2.7% | 0.00% | – |
| Q2 2019 | $92,000 | -96.2% | 54,087 | -92.5% | 0.00% | – |
| Q1 2019 | $2,441,000 | +20.7% | 724,315 | +4.6% | 0.00% | – |
| Q4 2018 | $2,022,000 | -52.9% | 692,408 | -0.6% | 0.00% | – |
| Q3 2018 | $4,291,000 | -10.3% | 696,443 | +7.5% | 0.00% | – |
| Q2 2018 | $4,782,000 | +61.8% | 647,709 | +43.8% | 0.00% | – |
| Q1 2018 | $2,956,000 | -19.9% | 450,332 | +2.8% | 0.00% | – |
| Q4 2017 | $3,689,000 | -25.8% | 438,277 | +1.8% | 0.00% | – |
| Q3 2017 | $4,971,000 | +2.0% | 430,457 | +3.2% | 0.00% | – |
| Q2 2017 | $4,872,000 | +10.3% | 416,966 | +16.6% | 0.00% | – |
| Q1 2017 | $4,416,000 | -0.6% | 357,645 | +9.7% | 0.00% | – |
| Q4 2016 | $4,442,000 | -28.2% | 326,037 | +4.9% | 0.00% | -100.0% |
| Q3 2016 | $6,188,000 | +68.2% | 310,895 | +9.5% | 0.00% | – |
| Q2 2016 | $3,678,000 | +250.0% | 283,795 | +152.5% | 0.00% | – |
| Q1 2016 | $1,051,000 | -49.0% | 112,395 | +10.5% | 0.00% | – |
| Q4 2015 | $2,062,000 | +86.4% | 101,723 | +113.3% | 0.00% | – |
| Q1 2015 | $1,106,000 | – | 47,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |